188 related articles for article (PubMed ID: 10321608)
41. Pemphigus--diseases of antidesmosomal autoimmunity.
Udey MC; Stanley JR
JAMA; 1999 Aug; 282(6):572-6. PubMed ID: 10450720
[No Abstract] [Full Text] [Related]
42. Envoplakin and periplakin are the paraneoplastic pemphigus antigens.
Kiyokawa C
Kurume Med J; 1999; 46(1):71-8. PubMed ID: 10319615
[TBL] [Abstract][Full Text] [Related]
43. Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans.
Chorzelski T; Hashimoto T; Maciejewska B; Amagai M; Anhalt GJ; Jablonska S
J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):393-400. PubMed ID: 10459112
[TBL] [Abstract][Full Text] [Related]
44. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes.
Aoyama Y; Owada MK; Kitajima Y
Eur J Immunol; 1999 Jul; 29(7):2233-40. PubMed ID: 10427986
[TBL] [Abstract][Full Text] [Related]
45. [Paraneoplastic pemphigus. Induction of autoantibodies against structural proteins in the skin].
Zillikens D; Bröcker EB
Hautarzt; 1994 Dec; 45(12):827-33. PubMed ID: 7843961
[TBL] [Abstract][Full Text] [Related]
46. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
Hashimoto T; Amagai M; Garrod DR; Nishikawa T
Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
[TBL] [Abstract][Full Text] [Related]
47. Pemphigus vulgaris antigen is a desmosomal desmoglein.
Kárpáti S; Amagai M; Prussick R; Stanley JR
Dermatology; 1994; 189 Suppl 1():24-6. PubMed ID: 8049558
[TBL] [Abstract][Full Text] [Related]
48. [Ultrastructural study of pemphigus foliaceus and pemphigus vulgaris antigens. Apropos of 2 cases].
Bedane C; Bernard P; Dang PM; Amici JM; Catanzano G; Bonnetblanc JM
Ann Dermatol Venereol; 1991; 118(11):888-90. PubMed ID: 1724140
[No Abstract] [Full Text] [Related]
49. Detection of anti-envoplakin and anti-periplakin autoantibodies by ELISA in patients with paraneoplastic pemphigus.
Huang Y; Li J; Zhu X
Arch Dermatol Res; 2009 Oct; 301(10):703-9. PubMed ID: 18820940
[TBL] [Abstract][Full Text] [Related]
50. Prognostic factors of paraneoplastic pemphigus.
Leger S; Picard D; Ingen-Housz-Oro S; Arnault JP; Aubin F; Carsuzaa F; Chaumentin G; Chevrant-Breton J; Chosidow O; Crickx B; D'incan M; Dandurand M; Debarbieux S; Delaporte E; Dereure O; Doutre MS; Guillet G; Jullien D; Kupfer I; Lacour JP; Leonard F; Lok C; Machet L; Martin L; Paul C; Pignon JM; Robert C; Thomas L; Weiller PJ; Ferranti V; Gilbert D; Courville P; Houivet E; Benichou J; Joly P
Arch Dermatol; 2012 Oct; 148(10):1165-72. PubMed ID: 22801794
[TBL] [Abstract][Full Text] [Related]
51. Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes.
Kárpáti S; Amagai M; Prussick R; Cehrs K; Stanley JR
J Cell Biol; 1993 Jul; 122(2):409-15. PubMed ID: 8320263
[TBL] [Abstract][Full Text] [Related]
52. The location of binding sites of pemphigus vulgaris and pemphigus foliaceus autoantibodies: a post-embedding immunoelectron microscopic study.
Zhou S; Ferguson DJ; Allen J; Wojnarowska F
Br J Dermatol; 1997 Jun; 136(6):878-83. PubMed ID: 9217820
[TBL] [Abstract][Full Text] [Related]
53. Epitope spreading in paraneoplastic pemphigus: autoimmune induction in antibody-mediated blistering skin diseases.
Chan LS
Arch Dermatol; 2000 May; 136(5):663-4. PubMed ID: 10815861
[No Abstract] [Full Text] [Related]
54. Characterisation of inflammatory infiltrates in lesions of the oral mucosa, skin, and bronchioles in a case of paraneoplastic pemphigus.
Iida K; Yamaguchi F; Hibi K; Tate G; Ohyama B; Numata S; Hashimoto T; Sato M; Uchida T; Sueki H
Eur J Dermatol; 2012; 22(1):154-5. PubMed ID: 22370168
[No Abstract] [Full Text] [Related]
55. Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus.
Ohyama M; Amagai M; Hashimoto T; Nousari HC; Anhalt GJ; Nishikawa T
J Am Acad Dermatol; 2001 Apr; 44(4):593-8. PubMed ID: 11260531
[TBL] [Abstract][Full Text] [Related]
56. Paraneoplastic pemphigus without detectable anti-plakin antibodies in a patient with non-Hodgkin lymphoma.
Moreno-Artero E; Querol-Cisneros E; Rodríguez-Garijo N; Tomás-Velázquez A; Idoate MA; Ishii N; Hashimoto T; España A
Ann Hematol; 2018 Mar; 97(3):543-544. PubMed ID: 29143865
[No Abstract] [Full Text] [Related]
57. A patient with immunological features of paraneoplastic pemphigus in the absence of a detectable malignancy.
Verrini A; Cannata G; Cozzani E; Terracini M; Parodi A; Rebora A
Acta Derm Venereol; 2002; 82(5):382-4. PubMed ID: 12430743
[No Abstract] [Full Text] [Related]
58. Late development of antidesmoglein 1 antibodies in pemphigus vulgaris: correlation with disease progression.
Miyagawa S; Amagai M; Iida T; Yamamoto Y; Nishikawa T; Shirai T
Br J Dermatol; 1999 Dec; 141(6):1084-7. PubMed ID: 10606856
[TBL] [Abstract][Full Text] [Related]
59. Further analysis of pemphigus autoantibodies and their use in studies on the heterogeneity, structure, and function of desmosomes.
Jones JC; Yokoo KM; Goldman RD
J Cell Biol; 1986 Mar; 102(3):1109-17. PubMed ID: 3512579
[TBL] [Abstract][Full Text] [Related]
60. Exacerbation of pemphigus foliaceus after tetanus vaccination accompanied by synthesis of auto-antibodies against paraneoplastic pemphigus antigens.
Korang K; Ghohestani R; Krieg T; Uitto J; Hunzelmann N
Acta Derm Venereol; 2002; 82(6):482-3. PubMed ID: 12575868
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
